HIGHLIGHTS
- who: George R. Uhl from the University of Murcia, Spain have published the paper: Selecting the appropriate hurdles and endpoints for pentilludin, a novel antiaddiction pharmacotherapeutic targeting the receptor type protein tyrosine phosphatase D, in the Journal: (JOURNAL)
- what: The authors provide several possible examples below. continue development by providing tax benefits and a period of exclusivity .
SUMMARY
Urgent public health needs Development of safe and effective medications to aid prevention and treatment of stimulant, opioid and stimulant + opioid use disorders are urgent public health needs. There are no FDAapproved medications . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.